Clinical Trials Directory

Trials / Unknown

UnknownNCT05765968

Cumulative Live Birth After Double Stimulation Protocol Versus Antagonist Protocol for Poor Ovarian Responders

Cumulative Live Birth Rates in the Same Cycle Double Stimulation Protocol Versus a Two-cycle Antagonist Stimulation Protocol in IVF Patients With a Poor Prognosis: a Randomized Clinical Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
1,198 (estimated)
Sponsor
Shandong University · Academic / Other
Sex
Female
Age
20 Years
Healthy volunteers
Accepted

Summary

To compare the difference in cumulative live birth rates within one year between double stimulations protocol and two-cycle antagonist protocol in poor ovarian responders.

Detailed description

The theory of multicyclic development of follicles during the menstrual cycle prompted new approaches to ovarian stimulation such as double stimulation within the same menstrual cycle, in both follicular and luteal phases. The double ovarian stimulation protocol has been proposed to optimize the number of oocytes retrieved within the shortest possible timeframe.In general, the aim of DUOSTIM is to obtain the highest number of oocytes in the shortest time, thus avoiding waste of time, which is crucial for these patients.

Conditions

Interventions

TypeNameDescription
PROCEDUREDouble Stimulation Protocolcummulative live birth outcome after two cycles of in virto fertilization using double stimulation protocol, which refers to two cycles of ovarian stimulation in both follicular phase and luteal phase within the same menstrual cycle
PROCEDUREAntagonist Stimulation Protocolcummulative live birth outcome within no more than two cycles of in virto fertilization using classical antagonist protocol

Timeline

Start date
2023-03-14
Primary completion
2026-03-01
Completion
2026-04-01
First posted
2023-03-13
Last updated
2023-03-14

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05765968. Inclusion in this directory is not an endorsement.